Bracing for Walking in Parkinson's Disease
Impact of Carbon Fiber AFOs on Gait and Resulting Changes in Quality of Life Across Time in Persons With PD
1 other identifier
interventional
10
1 country
1
Brief Summary
Parkinson disease (PD) is a progressive neurological disease that results in characteristic gait dysfunction. Gait problems include decreased velocity, decreased stride length, difficulty with initiation of gait, postural stability problems and alteration in joint kinematics.1 In this typically older patient population, these gait deviations affect their participation in household and community activities. The standard of care is currently focused on therapeutic exercise and cueing of various types (visual, auditory, verbal). Current interventions have not been demonstrated to markedly improve gait kinematics, so there is a need to identify interventions that could improve gait performance in this population. Lower extremity bracing is a common and well-established intervention for gait dysfunction with other populations, including stroke and brain injury. The braces allow for improved stability, sensory feedback, and consistent tactile cues to allow patients to have the best gait mechanics with each step. It is reasonable to hypothesize that appropriate bracing may have the potential to improve gait function and kinematics in PD since these patient often have gastroc-soleus weakness. Data from our early pilot studies indicates that bracing individuals with PD can positively impact their mobility. This includes improvements in velocity, step length, and dynamic balance. Additional data supported an upward trend in quality of life.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Sep 2016
Longer than P75 for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
September 1, 2016
CompletedFirst Submitted
Initial submission to the registry
June 13, 2017
CompletedFirst Posted
Study publicly available on registry
June 19, 2017
CompletedPrimary Completion
Last participant's last visit for primary outcome
December 1, 2020
CompletedStudy Completion
Last participant's last visit for all outcomes
December 1, 2020
CompletedResults Posted
Study results publicly available
March 23, 2022
CompletedMarch 23, 2022
February 1, 2022
4.3 years
June 13, 2017
December 21, 2021
February 25, 2022
Conditions
Outcome Measures
Primary Outcomes (1)
Change in Gait Capacity as Assessed b 6-Minute Walk Test
The 6 Minute Walk Test (6MWT) is a test of walking (gait) endurance and walking velocity and measures the distance a subject can walk indoors on a flat, hard surface in a period of 6 minutes, using assistive devices, as necessary. The test is a reliable and valid evaluation of functional exercise capacity and is used as a sub-maximal test of aerobic capacity and endurance. The test will be used to determine participant's gait efficiency at baseline and at 6 months. While the total distance covered during six minutes (6MWTD) is often used as the standard measurement of gait capacity (i.e., the maximum distance one can achieve), the endurance (i.e., ability to maintain speed over a prolonged time) can be inferred by the gait speed trajectory (GST) during the 6MW test (6MWGST).
Baseline and 6 months
Secondary Outcomes (2)
Change in Step Length
Baseline and 6 months
Change in Temporal Spatial Gait Parameters Using the Computerized Gait Analysis System
Baseline and 6 months
Study Arms (2)
Carbon Fiber Ankle Foot Orthosis (AFO)
EXPERIMENTALFor the bracing group, the participants will wear custom fabricated carbon fiber braces in addition to participating in a daily walking program and 7 visits of PT.
Control Group, Walking Program Only
ACTIVE COMPARATORThe participants in this group will be prescribed a daily home walking walking program and 7 visits of PT.
Interventions
Custom AFOs in conjunction with a walking program, working up to walking 30 minutes 6 days a week.
standardized walking/exercise program without any brace or AFO
Eligibility Criteria
You may qualify if:
- Confirmed diagnosis of Parkinson's Disease according to the UK brain bank criteria.5
- Age between 30 and 85.
- Measurable decrement in gait velocity (between 35 and 15 percent below age-predicted norms for self-selected walking velocity) as measured by the 6 MWT
- Hoehn and Yahr stage 2-3.
- Less than 10 full heel raises in single limb stance bilaterally.
You may not qualify if:
- Body mass index greater than 40.
- Passive dorsiflexion range of motion less than approximately neutral (90 degrees)
- Any other uncontrolled health condition for which gait training is contraindicated
- Self-report of \> 1 fall/month
- A score of 11 or less on the Short Orientation-Memory-Concentration Test of Cognitive Impairment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
UT Southwestern
Dallas, Texas, 75235, United States
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Results Point of Contact
- Title
- Staci Shearin
- Organization
- UtexasSouthwestern
Study Officials
- PRINCIPAL INVESTIGATOR
Staci Shearin, Masters
UT Southwestern
Publication Agreements
- PI is Sponsor Employee
- No
- Restrictive Agreement
- No
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Assistant Professor
Study Record Dates
First Submitted
June 13, 2017
First Posted
June 19, 2017
Study Start
September 1, 2016
Primary Completion
December 1, 2020
Study Completion
December 1, 2020
Last Updated
March 23, 2022
Results First Posted
March 23, 2022
Record last verified: 2022-02
Data Sharing
- IPD Sharing
- Will not share